Navigation Links
Immune Response May Hinder Stem Cell Treatments
Date:8/18/2008

This unexpected reaction must be overcome to ensure therapeutic success, experts say

MONDAY, Aug. 18 (HealthDay News) -- Human embryonic stem cells trigger an immune response in mice, a new study finds. If the same thing happens in humans, it could prove a big roadblock to stem cell-based treatments, researchers say.

Researchers at Stanford University School of Medicine found that common anti-rejection medications could counter the mice's immune response. However, the new finding dashes prior hopes that the immune system gave foreign embryonic stem cells a "free pass" through the body.

"It's getting harder and harder to believe that these cells are immunoprivileged," senior author Dr. Joseph Wu, assistant professor of cardiovascular medicine and of radiology at Stanford, said in a news release issued by the university. "In fact, the rejection of these cells confirms our suspicions that they do cause an immune response."

The findings were to be published in the Aug.18 online edition of the journal Proceedings of the National Academy of Sciences.

Embryonic stem cells form all cells in an embryo. Many researchers have suggested that the immune system ignores them to allow the growth of a fetus that contains both maternal and paternal genetic material. Such an immunological exemption would counter concerns about using cells therapeutically that don't exactly match the recipient's immune system.

After injecting human embryonic stem cells into mice, those cells died within 10 days in mice with good immune systems but survived and multiplied in the mice with impaired immune responses. Further injections into the normally functioning mice led to more rapid cell death, a sign that the mice's immune system was getting better at recognizing and rejecting the cells.

"The data is quite convincing," Wu said. "Based on these results, we believe that transplanting these cells into humans would also cause an immune response."

Medicating the mice with normal immune systems with a combination of two common anti-rejection compounds -- tacrolimus and sirolimus -- allowed those cells to survive for up to 28 days, the team said.

More information

The U.S. National Institutes of Health has more about stem cells.



-- Kevin McKeever



SOURCE: Stanford University School of Medicine, news release, Aug. 18, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. Immune deficiency linked to a type of eye cancer
3. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
4. Melanoma drug revs immune cells but cancer cells ignore it
5. Study identifies key player in the bodys immune response to chronic stress
6. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
7. UVA researchers find important clue to immune infertility
8. M.D. Anderson-led team reports possible key to autoimmune disease
9. Their immune cells, fighting your cancer
10. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
11. Occupational exposures may be linked to death from autoimmune disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Immune Response May Hinder Stem Cell Treatments
(Date:12/7/2016)... ... December 07, 2016 , ... "ProBrand Flip allows FCPX editors ... said Christina Austin - CEO of Pixel Film Studios. , ProBrand Flip includes 30 ... drop zones. Editors can select from a variety of flip book animations. In Addition, ...
(Date:12/7/2016)... ... December 07, 2016 , ... Bioelectronic ... Plus for consumers and healthcare professionals to manage chronic and acute pain. ... treatment modalities available in a single device. The announcement is part of ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... “The Road ... is an everyday trial, not a one hour a week showing of hands. “The ... businessman. , Tom begins, “Perhaps you are familiar with the brass ring that you ...
(Date:12/7/2016)... ... ... With God: Inspirational Lessons from My Life's Journey”: a sometimes serious, sometimes humorous ... in their lives. “Walking With God: Inspirational Lessons from My Life's Journey” is the ... , Sanford says, “I enjoy sharing the true stories in my book as examples ...
(Date:12/7/2016)... ... (PRWEB) December 07, 2016 , ... ... for individuals impacted by cerebral cavernous angiomas, was awarded a grant from the ... patient engagement program. New Mexico has more people with cavernous angioma than anywhere ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... The pen needles market is projected to ... billion in 2016, growing at a CAGR of 11.2% ... Over the years, the pen needles market has witnessed ... growing demand for safety injections in the healthcare industry. ... pen needles with an aim to reduce pain, increase ...
(Date:12/6/2016)... -- Nearly 30 million people in the United ... 1 However, nearly 40% of diabetes patients in ... significant glucose variability. 2 These patients are at high ... left untreated, hyperglycemia can lead to cardiovascular disease, nerve ... As part of Diabetes Awareness Month, ...
(Date:12/6/2016)... opioids commonly used for pain management for workplace injuries, employers now ... to nationwide fatalities. The synthetic opioid called U-47700, or ... morphine, resulting in likelihood of addiction, abuse or death. ... , , ... for HMC HealthWorks, explained the opioid drug is less expensive yet ...
Breaking Medicine Technology: